Delivery Order SPE2DB20D9331-SPE2DB25FL1Q2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The contract is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA's SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $61,902.91 for MACI 3cm x 5cm implant sheets. The award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025, under a firm fixed-price contract with no set-aside designation. The contract is being funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the contractor's Park...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $53,318.24 contract is for the delivery of MACI 3CM X 5CM implant sheets to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth up to $57,317.20 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, which has a period of performance through April 16, 2024, is for the supply of MACI 3CM X 5CM Implant Sheets. This order was placed under DMS Pharmaceutical Group's existing Indefinite Delivery Vehicle (IDV) contract SPE2DB24FSW93 with DLA, which has a ceiling value of up...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $61,902.90 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4567084856 MACI 3CM X 5CM IMPLANT SHEETS, a specialized medical product, with a completion date of February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $61,538.77 by the Defense Logistics Agency (DLA) on August 8, 2025. The delivery order, with an ultimate completion date of August 29, 2025, is for MACI 3cm x 5cm implant sheets—a regenerative medicine product used in cartilage repair and orthopedic applications. This award was issued without a set-aside designation, allowing...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4564165994 MACI 3CM X 5CM implant sheets with a potential value of $57,317.20. The contract has a completion date of March 12, 2024 and was awarded on February 20, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and...
- This is a $61,902.91 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of MACI 3CM X 5CM IMPLANT SHEETS and has an ultimate completion date of February 18, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $57,317.20 award is for the supply of MACI 3CM X 5CM IMPLANT SHEETS, a medical device product, with an ultimate completion date of October 1, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $53,318.24, is for the delivery of MACI 3CM X 5CM Implant Sheets. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the DLA to issue firm fixed-price orders for a comprehensive range of...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1Q2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for DLA contracts. The company specializes in distributing branded and generic prescription drugs, biologics, medical consumables, and specialized pharmaceutical products to military and federal healthcare systems across the nation. This particular delivery order for MACI implant sheets—a regenerative medicine product used in orthopedic applications—reflects the company's portfolio of advanced pharmaceutical and medical device offerings that support the diverse medical supply requirements of the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.9k | 7/25/25 |